அனுராக் வார்ஷ்னி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அனுராக் வார்ஷ்னி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அனுராக் வார்ஷ்னி Today - Breaking & Trending Today

How Modi's Hindutva irrationality makes India's war on Covid-19 even more difficult

Ramdev and Narendra Modi at a yoga event in Delhi in 2014.
|
Adnan Abidi/Reuters
Earlier this month, the Ayush ministry offered detailed advice on how to build one’s immunity during the “Covid-19 Crisis”. To help ward off the dreaded disease, the ministry listed a series of specific recommendations, including, “Apply Sesame oil/Coconut oil/Cow Ghee. in both the nostrils in morning and evening.”
However, if one didn’t like putting stuff in one’s nose, the ministry offered an alternative: “Take 1 table spoon sesame oil or coconut oil in the mouth. Do not drink, swish in the mouth for 2 to 3 minutes and spit it off followed by warm water rinse [sic]”. ....

Madhya Pradesh , United States , Vijay Sankeshwar , Sarkari Sant , Mahatma Gandhi , Narendra Modi , Anurag Varshney , Rashtriya Swayamsevak Sangh , Usha Thakur , Patanjali Research Institute , Bharatiya Janata Party , Cow Ghee , North Karnataka , North America , Kumbh Mela , North Indian , Rss Bjp , Indutva Anti Science , India Vaccine , மத்யா பிரதேஷ் , ஒன்றுபட்டது மாநிலங்களில் , விஜய் சங்கேஸ்வர் , மகாத்மா காந்தி , நரேந்திர மோடி , அனுராக் வார்ஷ்னி , ரஷ்ற்ரிய சுவயம்செவக் சங் ,

Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August

Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August
Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August
The third-phase trials began in January, while the phase-2 trials were conducted over a three-month period between June and September last year and involved 110 patients.
2-DG has been studied in more than 200 clinical trials for the treatment of various cancers globally.
New Delhi:
With the government presenting DRDO-developed drug 2-DG as a potential game-changer in the fight against COVID-19, the clinical trial registry data suggests that the phase-3 trials for the medicine at over two dozen government and private hospitals and involving 220 patients may continue till August. ....

India General , Tamil Nadu , Harsh Vardhan , Patanjali Pallavi Thakur , Shivam Singh , Anurag Varshney , Indian Council Of Medical Research , Ministry Of Defence , Health Ministry , Indian Journal Of Medical Research , Technical Sciences , Patanjali Research Institute Acharya Balkrishna , Viney Jain Vishwa Bharti Institute , Institute Of Nuclear Medicine , Data Suggests , For Covid Drug , Continue Till August , Patanjali Research Institute , Acharya Balkrishna , Swami Narsingh Dev , Viney Jain , Jain Vishwa Bharti Institute , Rakesh Kumar Sharma , Saveetha Institute , National Academy , Medical Sciences ,

Phase-3 clinical trials for 2-DG may continue till Aug: Registry data

With the government presenting DRDO-developed drug 2-DG as a potential game-changer in the fight against COVID-19, the clinical trial registry data suggests that the phase-3 trials for the medicine at over two dozen government and private hospitals and involving 220 patients may continue till August.
The third-phase trials began in January, while the phase-2 trials were conducted over a three-month period between June and September last year and involved 110 patients.
While 2-DG has been studied in more than 200 clinical trials for the treatment of various cancers globally, trials to use it as a COVID-19 drug are apparently being done in India only and incidentally, a strong case for its therapeutic use against the novel coronavirus was made in a study paper last year that had Patanjali Research Institute s Acharya Balkrishna as the lead author. ....

India General , Tamil Nadu , Harsh Vardhan , Patanjali Pallavi Thakur , Shivam Singh , Anurag Varshney , Indian Council Of Medical Research , Ministry Of Defence , Health Ministry , Indian Journal Of Medical Research , Technical Sciences , Patanjali Research Institute Acharya Balkrishna , Viney Jain Vishwa Bharti Institute , Institute Of Nuclear Medicine , Patanjali Research Institute , Acharya Balkrishna , Swami Narsingh Dev , Viney Jain , Jain Vishwa Bharti Institute , Rakesh Kumar Sharma , Saveetha Institute , National Academy , Medical Sciences , Indian Journal , Medical Research , Indian Council ,

Registry data suggests phase-3 clinical trials for 2-DG at over 12 locations may continue till Augus- The New Indian Express

The third-phase trials began in January, while the phase-2 trials were conducted over a three-month period between June and September last year and involved 110 patients. ....

India General , Tamil Nadu , Harsh Vardhan , Patanjali Pallavi Thakur , Shivam Singh , Anurag Varshney , Indian Council Of Medical Research , Ministry Of Defence , Health Ministry , Indian Journal Of Medical Research , Technical Sciences , Patanjali Research Institute Acharya Balkrishna , Viney Jain Vishwa Bharti Institute , Institute Of Nuclear Medicine , Patanjali Research Institute , Acharya Balkrishna , Swami Narsingh Dev , Viney Jain , Jain Vishwa Bharti Institute , Rakesh Kumar Sharma , Saveetha Institute , National Academy , Medical Sciences , Indian Journal , Medical Research , Indian Council ,

Ramdev Claims Patanjali's Coronil For COVID-19 Cleared, Can Be Exported

Yoga teacher Ramdev today released a research paper on Coronil.
New Delhi:
Yoga teacher Ramdev on Friday released a research paper on what he called the first evidence-based medicine for COVID-19 by Patanjali - Coronil in presence of Union Health Minister Harsh Vardhan and Union Minister Nitin Gadkari.
Ramdev said that the research paper would clear all suspicions related to Coronil, which Patanjali says is an ayurvedic medicine for Covid. When we launched Coronil, people raised questions on its validity and asked if we followed scientific parameters. People think research can only happen in foreign countries. With this research, we have cleared all suspicions about Coronil, he said, according to news agency ANI. ....

Harsh Vardhan , Nitin Gadkari , Anurag Varshney , Union Health , Central Drug Standard Control Organisation , Ayush Ministry , Patanjali Research Institute , Nizam Institute Of Medical Sciences , World Health Organisation , Union Health Minister Harsh Vardhan , Union Minister Nitin , Drugs Controller General , Medical Sciences , Corona Virus , Coronavirus Medicine , Covid 19 Medicine , கடுமையான வர்தன் , நிடின் கட்காரி , அனுராக் வார்ஷ்னி , தொழிற்சங்கம் ஆரோக்கியம் , மைய மருந்து தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , ஆயுஷ் அமைச்சகம் , பதஞ்சலி ஆராய்ச்சி நிறுவனம் , நிஜாம் நிறுவனம் ஆஃப் மருத்துவ அறிவியல் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , தொழிற்சங்கம் ஆரோக்கியம் அமைச்சர் கடுமையான வர்தன் ,